Reboncel Brilliant BB Cream SPF 40

Reboncel Brilliant BB SPF 40 by

Drug Labeling and Warnings

Reboncel Brilliant BB SPF 40 by is a Otc medication manufactured, distributed, or labeled by ENBIOSCIENCE CO.,LTD. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

REBONCEL BRILLIANT BB SPF 40- zinc oxide cream 
ENBIOSCIENCE CO.,LTD

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Reboncel Brilliant BB Cream SPF 40

Drug Facts

Active ingredient

Zinc oxdie 0.8%

Purpose

Sunscreen

Uses

  • helps prevent sunburn
  • if used as directed with other sun protection measures ( see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

  • For external use only

Do not use

  • on damaged or broken skin

When using this product

  • keep out of eyes. Rinse with water to remove

Stop use and ask a doctor if

  • rash occurs

Keep out of reach of children.

  • If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • apply liberally 15 minutes before sun exposure
  • reapply:
  • after 80 minutes of swimming or sweating
  • immediately after towel drying
  • at least every 2 hours.
  • children under 6 months of age: ask a doctor.
  • Sun Protections Measures.
  • Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regurlarly use a sunscreen with a BroadSpectrum SPF value of 15 or higher and other sun protection measures including:
  • limit time in the sun, especially from 10 a.m. - 2 p.m.
  • wear long-sleeved shirts, pants, hats, and sunglasses

Other information

  • protect the product in this container from excessive heat and direct sun
  • refer to inset for complete labeling information

Inactive ingredients

Water, Cyclopentasiloxane, Butylene Glycol, Ethylhexyl Methoxycinnamate, Titanium Dioxide, Betaine, Cetyl Ethylhexanoate, Dimethicone, Squalane, Niacinamide, Polysorbate 60, Sodium Chloride, Cetyl PEG/PPG-10/1 Dimethicone, Zinc Oxide, Yellow Oxide Of Iron, Isoamyl p-Methoxycinnamate, Diethylamino Hydroxybenzoyl Hexyl Benzoate, Bentonite, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Stearic Acid, Red Oxide Of Iron, Chlorphenesin, Black Oxide Of Iron, Illicium Verum (Anise) Fruit Extract, Citrus Paradisi (Grapefruit) Fruit Extract, Nelumbium Speciosum Flower Extract, Paeonia Suffruticosa Root Extract, Scutellaria Baicalensis Root Extract, Tocopheryl Acetate, Sodium Hyaluronate, Centella Asiatica Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Portulaca Oleracea Extract, Talc, Althaea Rosea Flower Extract, Aloe Barbadensis Leaf Extract, Allantoin, Adenosine, Lysine HCl, Proline, Sodium Ascorbyl Phosphate, Acetyl Methionine, Theanine, Vitis Vinifera (Grape) Callus Culture Extract, Nelumbo Nucifera Callus Culture Extract, Panax Ginseng Callus Culture Extract, Fragrance

Questions?

E-mail: info@reboncelco.com

Principal Display Panel

REBONCEL

SPF 40, PA++

BRILLIANT
BB CREAM

INTENSIVE BLEMISH BALM PROGRAM
WITH UV CUT, WHITENING
AND WRINKLE CARE

BIOSCIENCE FORMULA

> BLEMISH BALM FORMULA
> HIGH PERFORMANCE UV CUT
> ULTRA WHITENING FORMULA
> WRINKLE CARE FORMULA
> MOISTURIZING CARE

50 ml

Reboncel Brilliant BB Cream SPF40 IC

REBONCEL BRILLIANT BB SPF 40 
zinc oxide cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 76192-101
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE0.8 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 76192-101-501 in 1 CARTON10/01/202210/01/2022
150 mL in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM02010/01/202210/01/2022
Labeler - ENBIOSCIENCE CO.,LTD (687650226)

Revised: 12/2022
 

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.